5

  

Imagine that you have been seeing a client  for 4 months. During treatment, you learn that he has been 5 years sober  but lately has felt an intense sense of anxiety and has requested a  referral to a psychiatrist. Upon returning to his counseling sessions,  you learn that the psychiatrist has prescribed diazepam, a  benzodiazepine. You are aware of the fact that the benzodiazepine  functions similarly to alcohol in the body. You are concerned about a  relapse because of this newly prescribed medication for the anxiety  disorder.
Sometimes the medication a  doctor chooses to treat a client’s symptoms is ineffective or  inappropriate, or it may not create the desired effect without  intolerable side effects. Under what circumstances does it become  necessary for a mental health professional to advocate for an  alternative treatment for a client? What ethical issues associated with  client treatment would mental health professionals need to address? Why  would a release of information be needed?
For  this Assignment, view the media case study titled “Anxiety Disorder  Case Study: Mary.”Assume the role of a mental health professional to  respond to the client call. Review the medication that the psychiatrist  prescribed and explain the expected effects and side effects of its use.  Plan a treatment strategy.
By Day 7
In a 2.5, APA-formatted paper, include the following:

An explanation of any concerns, ethical or otherwise, you may have regarding the client’s generalized anxiety disorder treatment
An explanation of the factors you would take into consideration in  developing a strategy to treat the client’s generalized anxiety disorder
An explanation of a treatment strategy for the client’s generalized  anxiety disorder along with a justification for your strategy
An explanation of how you would advocate for your treatment strategy

 
Lichtblau, L. (2011). Psychopharmacology demystified. Clifton Park, NY: Delmar, Cengage Learning.

Chapter 6, “Anxiolytic-Sedative-Hypnotic Drug Pharmacotherapy” (pp. 77–84)

 
Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.

Chapter 9, “Anxiety Disorders” (pp. 107-122)

Chapter 18, “Antianxiety Medication” (pp. 217-226)

 
  
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.

 
Use the DSM-5 to guide you through your understanding of the diagnostic criteria for mental disorders.

American Psychiatric Association. (2013). Highlights of changes from DSM IV-TR to DSM-5. Retrieved from http://www.dsm5.org/Documents/changes%20from%20dsm-iv-tr%20to%20dsm-5.pdf

As you review this document, consider the changes to the diagnostic criteria for anxiety disorders.